Communicable disease control: A 'Global Public Good' perspective

Health Policy and Planning

Volumn 19, Issue 5, 2004, Pages 271-278

  Smith, Richard ^a   Woodward, David ^b   Acharya, Arnab ^c   Beaglehole, Robert ^b   Drager, Nick ^b  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Communicable disease control; Globalization; Public goods

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DEVELOPING COUNTRY; GLOBALIZATION; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INFECTION CONTROL; INTERNATIONAL COOPERATION; MALARIA; MALARIA CONTROL; REVIEW; TUBERCULOSIS; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION;

HEALTH CARE AND PUBLIC HEALTH;

COMMUNICABLE DISEASE CONTROL; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; FINANCING, GOVERNMENT; HEALTH PRIORITIES; HUMANS; INTERNATIONAL COOPERATION; SOCIAL RESPONSIBILITY; SOCIAL WELFARE; WORLD HEALTH;

EID: 4344691623     PISSN: 02681080     EISSN: None     Source Type: Journal    
DOI: 10.1093/heapol/czh032     Document Type: Review

References (39)

1. Arhin-Tenkorang D, Conceição P. 2003. Beyond communicable disease control: health in the age of globalisation. In: Kaul I, Conceição P, Le Goulven K, Mendoza RU (eds). Providing Global Public Goods: managing globalisation. New York: Oxford University Press, chapter 4.
2. Arndt C, Lewis JD. 2000. The macro implications of HIV/AIDS in South Africa: a preliminary assessment. Africa Region Working Paper No. ARWPS-9. Washington, DC: World Bank.
3. Atkinson A, Stilitz J. 1980. Lectures in public economics. New York: McGraw Hill Publishing Co.
4. Aylward B, Acharya A, Englands S, Linkins J, Agocs M. 2003. Polio eradication. In: Smith RD, Beaglehole R, Drager N, Woodward D (eds). Global Public Goods for health: a health economic and public health perspective. Oxford: Oxford University Press, chapter 2.
5. Bart KJ, Foulds J, Patriarca P. 1996. Global eradication of poliomyelitis: benefit-cost analysis. Bulletin of the World Health Organization 74: 35-45.
6. Buse K, Walt G. 2000a. Global public-private partnerships: Part I - A new development in health? Bulletin of the World Health Organization 78: 549-61.
7. Buse K, Walt G. 2000b. Global public-private partnerships: Part II - What are the health issues for global governance? Bulletin of the World Health Organization 78: 699-709.
8. Buse K, Waxman A. 2001. Public-private health partnerships: a strategy for WHO. Bulletin of the World Health Organization 79: 748-54.
9. Butler D. 1997. Time to put malaria control on the global agenda. Nature 386: 535-6.
10. st Century. New York: Oxford University Press.
11. nd Edition. Cambridge: Cambridge University Press.
12. Evans D, Tandon A, Murray CJL, Lauer JA. 2001. Comparative efficiency of national health systems: cross national econometric analysis. British Medical Journal 323: 14-21.
13. Fidler D. 1996. Globalisation, international law, and emerging infectious diseases. Emerging Infectious Diseases 2: 77-84.
14. Fidler D. 1997. Return of the fourth horseman: emerging infectious diseases and international law. Minnesota Law Review 81: 771-868.
15. Fidler D. 1998. Legal issues associated with antimicrobial drug resistance. Emerging Infectious Diseases 4: 169-77.
16. Fidler DP. 2003. International law. In: Smith RD, Beaglehole R, Drager N, Woodward D (eds). Global Public Goods for health: a health economic and public health perspective. Oxford: Oxford University Press, chapter 9.
17. Folland S, Goodman A, Stano M. 1997. The economics of health and health care. New Jersey: Prentice Hall, chapter 22.
18. Gallagher R. 1997. Global initiative takes shape slowly. Science 277: 309.
19. Ghosh J. 2003. Medical knowledge. In: Smith RD, Beaglehole R, Drager N, Woodward D (eds). Global Public Goods for health: a health economic and public health perspective. Oxford: Oxford University Press, chapter 6.
20. Jamison D, Frenk J, Knaul F. 1998. International collective action in health: objectives, functions and rationale. The Lancet 351: 514-7.
21. Koivusalo M, Ollila E. 1997. Making a healthy world: agencies, actors and policies in international health. London: Zed Books.
22. Kumaranayake L, Conteh L, Kurowski C, Watts C. 2001. Preliminary estimates of the cost of expanding TB, Malaria and HIV/AIDS activities for Sub-Saharan Africa. Working Paper No. WG5:26. Geneva: Commission on Macroeconomics and Health.
23. LaFond A. 1995. Sustaining primary health care. London: Earthscan.
24. Mons B, Klasen E, van Kessel R, Nchinda T. 1998. Partnership between south and north crystalises around malaria. Science 279: 498-9.
25. Mooney G, Dzator J. 2003. Global public goods for health: a flawed paradigm? In: Smith RD, Beaglehole R, Woodward D, Drager N (eds). Global Public Goods for health: a health economic and public health perspective. Oxford: Oxford University Press, chapter 12.
26. Powles J, Comim F. 2003. Public health infrastructure and knowledge. In: Smith RD, Beaglehole R, Woodward D, Drager N (eds). Global Public Goods for health: a health economic and public health perspective. Oxford: Oxford University Press, chapter 8.
27. Preker AS, Harding A, Travis P. 2000. "Make or buy" decisions in the production of health care goods and services: new insights from institutional economics and organizational theory. Bulletin of the World Health Organization 78: 779-90.
28. Sandler T. 1997. Global challenges: an approach to environmental, political and economic problems. Cambridge: Cambridge University Press: chapter 5.
29. Sandler T, Arce D. 2002. A conceptual framework for understanding global and transnational public goods for health. Fiscal Studies 23: 195-222.
30. Smith RD, Coast J. 1998. Controlling antimicrobial resistance: a proposed transferable permit market. Health Policy 43: 219-32.
31. Smith RD, Coast J. 2003. Antimicrobial drug resistance. In: Smith RD, Beaglehole R, Woodward D, Drager N (eds). Global Public Goods for health: a health economic and public health perspective. Oxford: Oxford University Press, chapter 4.
32. Smith RD, Beaglehole R, Woodward D, Drager N (eds). 2003. Global Public Goods for health: a health economic and public health perspective. Oxford: Oxford University Press.
33. Smith RD, Woodward D. 2003. Global public goods for health: use and limitations. In: Smith RD, Beaglehole R, Woodward D, Drager N (eds). Global Public Goods for health: a health economic and public health perspective. Oxford: Oxford University Press, chapter 13.
34. Szreter S. 1988. The importance of social intervention in Britain's mortality decline c.1850-1914: a reinterpretation of the role of public health. Journal of the Society of Social History and Medicine 1: 1-37.
35. Thorsteinsdóttir H, Daar AS, Smith RD, Singer PA. 2003. Genomics knowledge. In: Smith RD, Beaglehole R, Woodward D, Drager N (eds). Global Public Goods for Health: a health economic and public health perspective. Oxford: Oxford University Press, chapter 7.
36. Tobin J. 1978. A proposal for Monetary Reform. Eastern Economic Journal 4: 153-9.
37. Varian H. 1992. Microeconomic analysis. New York: W.W. Norton and Company.
38. WHO. 2000. Global Polio Eradication Initiative: Strategic Plan, 2001-2005. WHO/Polio/00.05, Department of Vaccines and Biologicals. Geneva: World Health Organization.
39. Woodward D, Smith RD. 2003. Global Public Goods for health: concepts and issues. In: Smith RD, Beaglehole R, Woodward D, Drager N (eds). Global Public Goods for health: a health economic and public health perspective. Oxford: Oxford University Press, chapter 1.